Kunkel Lori Anne plan to sell securities of Enliven Therapeutics, Inc. under Form 144

Kunkel Lori Anne filed Form 144 to notify SEC of plan to sell 20000 units of Enliven Therapeutics, Inc. securities around 2026-06-05, with aggregate market value of $709,800.00. The total outstanding units is 61000000.0. The amount planned to be sold represents 0.03% of total outstanding units;